Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Perrigo CEO defends Elan acquisition

05:05 EDT 30 Jul 2013 | SCRIP

In a conference call later in the day, Perrigo's CEO Joseph Papa presented his rationale for the transaction. However, the markets were unconvinced. Perrigo's shares closed 7% down on 29 July at $125.17. Elan's shares, meanwhile, closed 4% up at $15....

Original Article: Perrigo CEO defends Elan acquisition


More From BioPortfolio on "Perrigo CEO defends Elan acquisition"

Search BioPortfolio:

Searches Linking to this Story